Module 9 - Respiratory System

0.0(0)
Studied by 3 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/18

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:02 PM on 9/11/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

19 Terms

1
New cards

Autonomic Control of Airways

Bronchioles

  • Lined with smooth muscle that controls amount of air entering lungs

Sympathetic Branch

  • Activates beta2–adrenergic receptors and causes bronchiolar smooth muscle to relax

  • The airway diameter increases (bronchodilation)

Parasympathetic Branch

  • Causes bronchiolar smooth muscle to contract

  • The airway diameter decreases (bronchoconstriction)


2
New cards

Administration of Pulmonary Drugs by Inhalation

Suspension of droplets or particles in a gas.

Rapid and efficient route.

Shorter duration, reduced side effects, difficult to measure dose.

3
New cards

Aerosol Therapy Devices

Nebulizer

  • Vaporizes liquid drug into fine mist.

  • Uses small machine and face mask.

Metered-Dose Inhaler (MDI)

  • Propellant delivers measured dose of drug.

  • Patient times inhalation to puffs of drug.

  • Can be used with a spacer.

Dry Powder Inhaler (DPI)

  • Patient inhales powdered drug.

  • Device activated by inhalation.

Soft Mist Inhaler (SMI)

  • Propellant-free, soft mist aerosol delivery device.

  • Less effort needed to coordinate compared to MDI.


4
New cards

Asthma

Chronic inflammatory disorder of the airways characterized by:

  • Paroxysmal or persistent symptoms.

  • Dyspnea, chest tightness, wheezing, sputum production & cough.

  • Airway hyper-responsiveness to a variety of stimuli (triggers).

Bronchospasm

  • Constriction of the muscles in the walls of the bronchioles caused by inflammatory mediators.

Hyper-reactivity

  • An exaggerated response of bronchial smooth muscles to trigger stimuli.

Airway remodelling

  • Refers to structural changes, including a change in the extracellular matrix in the airway wall, leading to airflow obstruction.


5
New cards

Pharmacologic Therapy - Asthma

Reliever Medication

  • Patient should have on hand and take only when needed (during an attack, episode of shortness of breath or before exercising).

Controller Medication

  • Prevents asthma attacks and inflammation.

  • Take every day, even if no symptoms.

  • Acts slowly and works over the long-term.

  • Will not help in an asthma attack.


6
New cards

Short-Acting Beta-Adrenergic Agonists (SABA)

A reliever medication.

For quick relief of cough, chest tightening, wheezing, shortness of breath, etc.

Produces bronchodilation by stimulating beta receptors.

Ex. salbutamol, terbutaline


7
New cards

Long-Acting Beta-2 Agonists (LABA)

A controller medication.

Work slowly over a 12-hour period to keep airways open and muscles relaxed.

Similar mechanism of action to SABA.

Should never be used alone.

Ex. salmeterol, formoterol


8
New cards

Inhaled Corticosteroids (ICS)

A controller medication.

Most common and effective type of controller.

Inhibit inflammatory response at all levels.

Ex. fluticasone, budesonide, ciclesonide, beclomethasone, mometasone


9
New cards

Oral Corticosteroids

Used for short periods of time in acute, severe asthma.

Ex. prednisone, prednisolone, dexamethasone.

10
New cards

Leukotriene Receptor Antagonists

A controller medication.

Antagonizes the effects of leukotrienes, eosinophils, and other inflammatory cells.

Ex. montelukast.

11
New cards

Short-Acting Muscarinic Antagonists (SAMA)

A reliever medication.

Blocks muscarinic receptors in smooth muscle, therefore reducing parasympathetic tone, which leads to bronchodilation.

Ex. ipratropium

12
New cards

Long-Acting Muscarinic Antagonists (LAMA)

A controller medication.

Add-on therapy in moderate to severe asthma.

Similar to SAMA.

Ex. glycopyronium, tiotropium, umeclidinium, aclindinium.

13
New cards

Methylxanthines

Use as an ‘add on’ in patients who require high-dose corticosteroids.

Non-specific inhibition of phosphodiesterase, which causes mild bronchodilation.

Ex. theophylline.

14
New cards

Biologics

For severe, uncontrolled asthma despite high-dose ICS and additional controllers.

Reduced airway eosinophilic inflammation by targeting specific pathways.

Ex. anti-immunoglobulin E antibody, IL-5 inhibitors, IL 4 and 13 inhibitors.

15
New cards

Inhaled Combination Products

As effective as separate medication.

More convenient, enhanced adherence.

16
New cards

Chronic Obstructive Pulmonary Disease (COPD)

A progressive, largely preventable lung disease caused mainly by smoking.

Includes chronic bronchitis (inflammation and mucus) and emphysema (destruction of alveoli).

17
New cards

Pharmacologic Therapy - COPD

Bronchodilators

  • Short-acting beta-adrenergic agonists (SABA)

  • Short-acting muscarinic antagonist (SAMA)

  • Long-acting beta-adrenergic agonists (LABA)

  • Long-acting muscarinic antagonists (LAMA)

Inhaled corticosteroids (ICS)

Other

  • Long-term oxygen therapy

  • N-acetylcysteine

  • Roflumilast

  • Antibiotics for infectious exacerbations.


18
New cards

Short-Acting Bronchodilators (Rescue)

Used for acute symptom relief.

SABA - salbutamol, terbutaline

SAMA - ipratropium

19
New cards

Long-Acting Bronchodilators (Maintenance)

Use every day to keep airways open.

LABA - salmeterol, formoterol, indacaterol, olodaterol

LAMA - tiotropium, umelidinium, glycopyrronium, aclindinium